Authors : Hassnaa Sarhane; Maha Lhaloui; Chaouki El Bied; Leila Rhilam; Amina Etber; Nisrine Benouicha; Aziz Baidada

Volume/Issue : Volume 10 - 2025, Issue 10 - October

---

Google Scholar : https://tinyurl.com/y3jkxff5

Scribd : https://tinyurl.com/en23jypv

DOI : https://doi.org/10.38124/ijisrt/25oct1315

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Note : Google Scholar may take 30 to 40 days to display the article.

---

Abstract : Surgical treatment is the cornerstone in the management of invasive breast carcinoma.The evolution of therapeutic indications varies depending on tumor characteristics, with or without metastases.Surgery serves two main objectives in breast cancer:  Staging, in order to tailor adjuvant treatment.  Locoregional control of the disease. The multidisciplinary tumor board makes it possible to define the optimal therapeutic sequence, considering the patient’s age, comorbidities, breast imaging, and pathological findings.

Keywords : Breast Cancer, Radical Mastectomy, Multiple Myeloma, Surgery.

References :

1. Volume 36 > n◦3 > juillet 2021 http://dx.doi.org/10.1016/S0246-1064(20)42833-6
2. Sakorafas GH. Breast cancer surgery–historical evolution, current status and future perspectives. Acta Oncol 2001;40:5–18.
3. Vincent L, Margueritte F, Uzan J, Owen C, Seror J, Pouget N, et al. Synthèse des recommandations nationales et internationales concernant lesindications de la technique du ganglion sentinelle et du curage axillaire complémentaire après ganglion sentinelle positif dans la prise en charge des cancers du sein. Bull Cancer 2017;104:356–62.
4. https://www.santepubliquefrance.fr/maladieset-traumatismes/cancers/cancer-du-sein/documents/rapport-synthese/estimations-nationales-de-l-incidence-et-de-la-mortalite-par-cancer-enfrance-metropolitaine-entre-1990-et-2018-volume-1-tumeurs-solidesetud.
5. El-TamerM. Surgical options as quality of care indicatorsin breast cancer. J Surg Oncol 2009;99:393–4.
6. Or Z. Variations des pratiques chirurgicales dans la prise en charge des cancers du sein en France. 2017.
7. Anonyme. Facteurs pronostiques de l’évolution de la maladie locorégionale ou métastatique et facteurs prédictifs de la réponse au traitement. Cancers du sein non métastatiques. Standards, Options et Recommandations. 1996. (FNCLCC)
8. Balic M, Thomssen C, Würstlein R, Gnant M, Harbeck N. St. Gallen/Vienna 2019: a brief summary of the consensus discussion on the optimal primary breast cancer treatment. Breast Care 2019;14:103–10